Sign in

Renee Lo

About Renee W. Lo

Renee W. Lo, age 44, has served on Integra LifeSciences’ Board since 2022 and is currently Vice President, APAC, Sales Solutions at LinkedIn (since February 2025). She holds a B.S. in Computer Science from the University of British Columbia and an MBA from the University of Manchester, with leadership experience across Google, Microsoft, Amazon Web Services, and Amazon.com focused on cloud, AI/data, product development, and commercial strategy .

Past Roles

OrganizationRoleTenureCommittees/Impact
LinkedInVice President APAC, Sales SolutionsFeb 2025–presentLeads APAC commercial organization for Sales Solutions
GooglePartner CTO, APAC Regional DirectorOct 2022–Jan 2025Led partner technology organization across APAC
MicrosoftGeneral Manager, Data & AI (Asia)2019–Sep 2022Led data and AI business in Asia
Amazon Web ServicesRegional Technology Team Leader2015–2019Built regional technology teams
Amazon.comGlobal Business Development (Telecom, Devices, New Services)2015–2019Ran global BD team focusing on telecom, devices, services
Microsoft / SAP / Pivotal (North America)Various roles in collaborative and cloud technologiesNot disclosedLeadership roles; >13 years in North America

External Roles

Company/InstitutionRoleTenureBoard/Committee
Public company boardsNone (no current public company directorships)

Board Governance

  • Committee assignments: Compensation Committee Chair (appointed April 1, 2025); current committee members are Lo (Chair), Graves, and Hill; 2024 meetings: 9 .
  • Independence: The Board determined all non-employee directors are independent; only the CEO (Poul) and Executive Chairman (Essig) are non-independent, so Lo is independent .
  • Board activity: Board held 7 regular and 2 special meetings in 2024; each incumbent director attended at least 75% of Board and applicable committee meetings .
  • Executive sessions: Independent directors met at least twice in executive session without management .
  • Annual meeting attendance: All directors standing for re-election attended the 2024 annual meeting .
  • Special committee service: Member of the CEO Search Committee in 2024; the committee met 15 times and was dissolved upon CEO appointment .
  • Committee interlocks: Compensation Committee members (Bradley, Lo, Graves) had no relationships requiring disclosure; no insider participation interlocks .

Fixed Compensation

ComponentAmount/StructureNotes
Annual Cash Retainer$80,000Payable in cash, restricted stock, or 50/50 cash/stock by director election; 2024–2025 period
Committee Chair Fee (Compensation)$15,000Annual cash fee for Compensation Committee Chair
Annual Equity Grant (Restricted Stock)$220,000 grant-date fair value$270,000 for Chairman; restricted stock granted annually
Travel/Out-of-PocketReasonable expenses reimbursedStandard practice

2024 Director Compensation (actual amounts reported):

MetricValue
Fees Earned or Paid in Cash (2024)$80,000
Stock Awards (2024)$220,009 (grant-date fair value under ASC 718)
Total (2024)$300,009

Performance Compensation

Award TypePerformance Metric(s)Vesting2024 Design
Director equity (restricted stock)Not performance-based (no disclosed metrics for directors)One-year vest; 2024 awards granted May 9, 2024, vest May 9, 2025Annual grant in restricted stock; directors may also elect retainer in equity

No performance metrics (e.g., revenue, EBITDA, TSR) are disclosed for non-employee director compensation; director equity awards are time-based restricted stock .

Other Directorships & Interlocks

EntityRoleInterlock/Conflict
Other public company boardsNoneNo public board interlocks disclosed
Compensation Committee interlocksNoneCommittee members had no relationships requiring disclosure

Expertise & Qualifications

  • Digital transformation and global corporate strategy leadership across LinkedIn, Google, Microsoft, AWS, and Amazon.com .
  • Technical depth in cloud, AI/data, and collaborative technologies; experience in product development, commercial operations, and international business .
  • Education: B.S. Computer Science (UBC); MBA (University of Manchester) .

Equity Ownership

MetricValueDetails
Beneficial Ownership (shares)16,151As of Feb 28, 2025
Percent of Class<1%“Represents beneficial ownership of less than 1%”
Unvested Restricted Shares Outstanding (12/31/2024)8,696Part of 2024 annual equity grant; vests May 9, 2025
Hedging/PledgingProhibited by policyCompany insider trading policy prohibits hedging and pledging for all directors

Governance Assessment

  • Independence, attendance, and chair role signal strong engagement: Lo is independent, attended ≥75% of meetings in 2024 with the Board and committees, and now chairs the Compensation Committee (9 meetings in 2024) .
  • Alignment via equity: Annual director equity grants in restricted stock (time-based), plus retainer election flexibility; Lo’s 2024 total director compensation was $300,009 with $220,009 in equity, aligning with shareholder interests through ownership .
  • No conflicts or related-party exposure: No related-person transactions involving Lo disclosed; Compensation Committee interlocks report shows no relationships requiring disclosure .
  • Policy safeguards: Anti-hedging/pledging policy and clawback policy in place; majority voting for directors; strong governance highlights (independent Presiding Director; ESG oversight; committee self-evaluations) .
  • Shareholder support: Say-on-Pay approval was 98.8% in 2024, indicating broad investor support for the Company’s compensation framework overseen by the Compensation Committee .

RED FLAGS: None identified for Renee W. Lo in the latest proxy — no related-party transactions, no pledging/hedging, and independence affirmed .